Publications

peer-reviewed papers

We have a proven track record of frequently publishing our innovation in internationally regarded, leading scientific journals. Below you find the publications of the last years.

2022





Concept of a fully-implantable system to monitor tumor recurrence


Source:
kahlert u [AUTHOR]


Published on 2023-09-29




Oxidative stress genes define two subtypes of triple-negative breast cancer with prognostic and therapeutic implications


Source:
kahlert u [AUTHOR]


Published on 2023-07-31




Mendelian Randomization Analyses of Chronic Immune-Mediated Diseases, Circulating Inflammatory Biomarkers, and Cytokines in Relation to Liver Cancer


Source:
kahlert u [AUTHOR]


Published on 2023-06-10




Effects of Dendrimer-microRNA Nanoformulations against Glioblastoma Stem Cells


Source:
kahlert u [AUTHOR]


Published on 2023-03-29




Chromatin Regulator-Related Gene Signature for Predicting Prognosis and Immunotherapy Efficacy in Breast Cancer


Source:
kahlert u [AUTHOR]


Published on 2023-02-09




Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma


Source:
kahlert u [AUTHOR]


Published on 2023-02-04




Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation


Source:
kahlert u [AUTHOR]


Published on 2023-01-13




MYCBP2 expression correlated with inflammatory cell infiltration and prognosis immunotherapy in thyroid cancer patients


Source:
kahlert u [AUTHOR]


Published on 2022-12-30




The role of the ZEB1-neuroinflammation axis in CNS disorders


Source:
kahlert u [AUTHOR]


Published on 2022-11-19




COL10A1 allows stratification of invasiveness of colon cancer and associates to extracellular matrix and immune cell enrichment in the tumor parenchyma


Source:
kahlert u [AUTHOR]


Published on 2022-10-21




Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia


Source:
kahlert u [AUTHOR]


Published on 2022-08-08




A Novel Extracellular Matrix Gene-Based Prognostic Model to Predict Overall Survive in Patients With Glioblastoma


Source:
kahlert u [AUTHOR]


Published on 2022-07-05




Construction of ceRNA Networks Associated With CD8 T Cells in Breast Cancer


Source:
kahlert u [AUTHOR]


Published on 2022-06-27




Meta-analysis on reporting practices as a source of heterogeneity in in vitro cancer research


Source:
kahlert u [AUTHOR]


Published on 2022-06-20




Gender disparity regarding work-life balance satisfaction among German neuro-oncologists: a YoungNOA survey


Source:
kahlert u [AUTHOR]


Published on 2022-05-31

2021

Functional clustering analysis identifies specific subtypes of aldehyde dehydrogenase associated with glioma immunity
Source: kahlert u Published on 2022-02-04
Reducing sources of variance in experimental procedures in in vitro research
Source: kahlert u Published on 2022-01-17
Glutaredoxin 2 promotes SP-1-dependent CSPG4 transcription and migration of wound healing NG2 glia and glioma cells: Enzymatic Taoism
Source: kahlert u Published on 2021-12-24
Overexpression of Cystine/Glutamate Antiporter xCT Correlates with Nutrient Flexibility and ZEB1 Expression in Highly Clonogenic Glioblastoma Stem-like Cells (GSCs)
Source: kahlert u Published on 2021-12-10
Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples
Source: kahlert u Published on 2021-12-09
Current Technologies for RNA-Directed Liquid Diagnostics
Source: kahlert u Published on 2021-10-23
Longitudinal stability of molecular alterations and drug response profiles in tumor spheroid cell lines enables reproducible analyses
Source: kahlert u Published on 2021-10-10
Brain Immune Interactions-Novel Emerging Options to Treat Acute Ischemic Brain Injury
Source: kahlert u Published on 2021-09-28
A Preclinical Pipeline for Translational Precision Medicine-Experiences from a Transdisciplinary Brain Tumor Stem Cell Project
Source: kahlert u Published on 2021-09-28
Testing the Stability of Drug Resistance on Cryopreserved, Gene-Engineered Human Induced Pluripotent Stem Cells
Source: kahlert u Published on 2021-09-28
eLabFTW as an Open Science tool to improve the quality and translation of preclinical research
Source: kahlert u Published on 2021-09-01
Differential polarization and activation dynamics of systemic T helper cell subsets after aneurysmal subarachnoid hemorrhage (SAH) and during post-SAH complications
Source: kahlert u Published on 2021-07-10
Role of Adaptor Protein Myeloid Differentiation 88 (MyD88) in Post-Subarachnoid Hemorrhage Inflammation: A Systematic Review
Source: kahlert u Published on 2021-04-30
BCOR Internal Tandem Duplication Expression in Neural Stem Cells Promotes Growth, Invasion, and Expression of PRC2 Targets
Source: kahlert u Published on 2021-04-30
Proposed definition of competencies for surgical neuro-oncology training
Source: kahlert u Published on 2021-04-21

2020

Rapalink-1 Targets Glioblastoma Stem Cells and Acts Synergistically with Tumor Treating Fields to Reduce Resistance against Temozolomide
Source: kahlert u Published on 2020-12-29
Different Calculation Strategies Are Congruent in Determining Chemotherapy Resistance of Brain Tumors In Vitro
Source: kahlert u Published on 2020-12-18
Current biomarker-associated procedures of cancer modeling-a reference in the context of IDH1 mutant glioma
Source: kahlert u Published on 2020-11-22
Association between health insurance status and malignant glioma
Source: kahlert u Published on 2020-10-05
A computational guided, functional validation of a novel therapeutic antibody proposes Notch signaling as a clinical relevant and druggable target in glioma
Source: kahlert u Published on 2020-10-02
An inexpensive and easy-to-implement approach to a Quality Management System for an academic research lab
Source: kahlert u Published on 2020-08-15
Robot technology identifies a Parkinsonian therapeutics repurpose to target stem cells of glioblastoma
Source: kahlert u Published on 2020-05-29
A comparative pharmaco-metabolomic study of glutaminase inhibitors in glioma stem-like cells confirms biological effectiveness but reveals differences in target-specificity
Source: kahlert u Published on 2020-04-28
Targeting High Mobility Group Box 1 in Subarachnoid Hemorrhage: A Systematic Review
Source: kahlert u Published on 2020-04-17
Elevated Systemic IL-10 Levels Indicate Immunodepression Leading to Nosocomial Infections after Aneurysmal Subarachnoid Hemorrhage (SAH) in Patients
Source: kahlert u Published on 2020-02-29
Efficient Modulation of TP53 Expression in Human Induced Pluripotent Stem Cells
Source: kahlert u Published on 2019-12-29
Influence of synthesis methods on the internalization of fluorescent gold nanoparticles into glioblastoma stem-like cells
Source: kahlert u Published on 2019-12-04

For all complete listing of papers visit NCBI Pubmed: